BackInflaRx N.V. Overview
InflaRx N.V.

InflaRx N.V. Target Price

Analysts' average 12-month price target for InflaRx N.V. is $9.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.01

Average Target Price

$9.00347.8% upside

1 analysts in the last 4 months

High: $9 | Low: $9

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-13Raymond JamesStrong Buy$9347.8% upsideOpen
2025-12-03Leerink Partners$20.5% downsideOpen
2025-05-29Raymond James$20.5% downsideOpen
2023-01-06H.C. Wainwright$6198.5% upsideOpen

InflaRx N.V. (IFRX) FAQ

InflaRx N.V. (IFRX) currently reports a target price of $9. Use the charts on this page to explore InflaRx N.V.'s target price history and peer comparisons.

Analysts' average 12-month price target for InflaRx N.V. is $9, about 347.8% upside from the current share price of $2.01. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $9, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for InflaRx N.V., and consider following IFRX for alerts when major investors trade the stock.

InflaRx N.V. is classified in the Healthcare sector. On target price, it currently shows $9. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IFRX with unrelated industries.